J No. 2J279 ACI No. 59. 2002 GOVERNME NT GAZETTE. 17 JANUARY 200J MEDICINES AND RELATED SUBSTANCF..s AME....OMENT ACT. 2002 "(3) If the office of any member of the council becomes \'aeant before the expiration of the period for which ht: or sht: was appointed. tht: Minister may(. subject to the provisions of section 3,J appoinl another JX'rson to ho ld office for the unexpired pon ion of the period for which his or her predecessor was appointed.". 5 Substitution of s«tion 12 of Act 101 of 1965, as substituted b\' section 10 of Act 65 of 1974 and amended by section 7 of Act 90 of 1997 . 3. The following section is substitUled for section 12 of the principal Act: " Appointment of Registrar and Deputy Registrar of Medicines 12. (1 The Minister rna . after consultation with the council. a int a 10 Registrar and one or more Deputy Registrars or revoke such an appointment. (2) The Registrar shall exercise: the powers and perform the duties assigned to. or imposed upon. him or her in terms of this Act and such other powers and dUlies as may from time to time be assigned 10 or impose:d upon 15 him or her by the counci l. Minister or DireClOr·General. (3) A DepUEy Registrar shall assist the Registrar in the excrcise: of his or her powers and the performance of his or her duties and may. subject to the approval of the Registrar. exercise any power confe rred upon the Registrar." . 20 Substitution of section 18C of Act 101 of 1965, as inserted by section 12 of Act 90 of 1997 4. The following section is substitUied for section IBe of the principal Act: " Marketing or medicines IBC. The Minister shall. after consultation with the pharmaceutical 25 industTV and other stakeholders. make regulations relati n!! to the marketing of medicines. and such regulations shall also provide for an enforceable Code of Practice.·· . Amendment of section 22A of Act 101 of 1965, liS inserted by section 21 of Act 65 of 1974. amended by section 9 of Act 17 of 1979 1lnd substituted by section 13 of Act 30 90 of 1997 5. Section 22A of the principal Act is amended by(a} the substitution for paragraph (p} of subsection (6) of the fo llowing par.tgraph: "(p) the sale of a specified Schedule 5 or Schedule 6 substance by a manufacturer of or wholesale dealer in phannaceutical products 35 shall be recorded in a register which shall be kept in the prescribed manner. and shall be balanced so as to show clearly the quantity of every specified Schedule 5 or Schedule 6 substance remaining in stock as on the last day of March. June, September and December of each year. and such balancing shall be completed within the 14 days 40 followi ng each of the said dates;"; (b) the substitution for subsection (8) of the follow ing subsection: "(8) Subject to subsection (9). a (Schedule 7J Schedule 8 substance shall not be acquired by any person other than the Director·General fo r the purpose of providing a medical practitioner therewith. on the 45 p re~ribed conditions. for the treatment of a panicular patient of that medical practitioner upon such conditions as the Dircctor·Gcneral. on the recommendation of the council, may detemline.";